The FDA approved long-acting injectable somatrogon (Ngenla) for pediatric human growth hormone deficiency, developers Pfizer and OPKO Health announced this week. Somatrogon is indicated for children ...

NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) has approved NGENLA (somatrogon-ghla), a ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved long-acting once-weekly somatrogon for children with growth hormone deficiency. Somatrogon was ...

Growth hormone helps children grow in height and supports healthy metabolism. When a child does not have enough of this hormone, their growth may be slow. This is sometimes called growth failure.

The primary sign of growth hormone deficiency in children is short stature. Adults may have decreased muscle mass and increased body fat, as well as other problems such as heart disease and depression ...

A comparison of morning and evening growth hormone injection schedules in children with growth disorders showed no significant differences in sleep-wake patterns, sleep duration, or daytime activity, ...

Growth hormone injections increase muscle and energy in people with low hormone levels. HGH therapy is used for hormone deficiencies and certain chronic conditions. Side effects like swelling and ...

Acromegaly is a rare endocrine disorder characterised by the excessive secretion of growth hormone (GH), most frequently resulting from a benign pituitary adenoma. The consequent overproduction of ...

In the field of growth hormone secretagogues, Tesamorelin and CJC-1295 represent a fundamental divergence in ligand-receptor ...